XRAY logo

DENTSPLY SIRONA Inc. (XRAY) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

DENTSPLY SIRONA Inc. (XRAY) ist im Healthcare-Sektor taetig, zuletzt notiert bei $11.54 mit einer Marktkapitalisierung von 3B. Bewertet mit 48/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 8. Feb. 2026
48/100 KI-Bewertung Ziel $15.00 (+30.0%) MCap 3B Vol 6M

DENTSPLY SIRONA Inc. (XRAY) Gesundheitswesen & Pipeline-Uebersicht

CEODaniel T. Scavilla
Mitarbeiter14000
HauptsitzCharlotte, NC, US
IPO-Jahr1987

DENTSPLY SIRONA (XRAY) offers a comprehensive suite of dental solutions, from equipment to consumables, holding a significant position in the global dental market with a broad product portfolio and established distribution network, presenting a notable opportunity for long-term growth despite current profitability challenges.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 8. Feb. 2026

Investmentthese

Investing in DENTSPLY SIRONA (XRAY) presents a notable opportunity based on its established market position and potential for future growth. While the company currently faces profitability challenges, as reflected in its negative P/E ratio of -3.11 and a negative profit margin of -24.3%, its strong gross margin of 50.9% indicates underlying pricing power. The company's dividend yield of 4.65% offers an attractive income stream while investors await a turnaround. Key value drivers include the increasing adoption of digital dentistry, the growing demand for cosmetic dental procedures, and the company's ability to innovate and introduce new products. The company's beta of 1.02 suggests market-average volatility. Successful execution of strategic initiatives and improved operational efficiency could drive significant upside potential.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market Cap of $2.75B reflects its significant presence in the dental market.
  • Gross Margin of 50.9% demonstrates strong pricing power and efficient cost management.
  • Dividend Yield of 4.65% provides an attractive income stream for investors.
  • Negative P/E Ratio of -3.11 indicates current profitability challenges, requiring strategic improvements.
  • Beta of 1.02 suggests market-average volatility.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Broad product portfolio covering various dental needs.
  • Global distribution network and established market presence.
  • Strong brand reputation and long history in the dental industry.
  • Continuous innovation in digital dentistry and advanced materials.

Schwaechen

  • Negative profit margin and declining profitability.
  • High debt levels and interest expenses.
  • Exposure to currency fluctuations and economic cycles.
  • Dependence on third-party distributors in some markets.

Katalysatoren

  • Ongoing: Increasing adoption of digital dentistry solutions.
  • Ongoing: Expansion in emerging markets with growing dental care demand.
  • Upcoming: Launch of new and innovative dental products.
  • Ongoing: Strategic acquisitions to expand product portfolio and market reach.

Risiken

  • Ongoing: Intense competition from established players and emerging disruptors.
  • Potential: Regulatory changes and compliance requirements.
  • Potential: Product liability claims and recalls.
  • Ongoing: Economic downturns and reduced consumer spending on dental care.

Wachstumschancen

  • Expansion in Digital Dentistry: The increasing adoption of digital dentistry presents a significant growth opportunity for DENTSPLY SIRONA. The market for digital dentistry solutions, including CAD/CAM systems and imaging equipment, is projected to grow substantially over the next five years. By investing in and promoting its digital solutions, DENTSPLY SIRONA can capture a larger share of this expanding market.
  • Growth in Emerging Markets: Emerging markets, such as China and India, offer substantial growth potential due to their large populations and increasing access to dental care. DENTSPLY SIRONA can expand its presence in these markets by establishing local partnerships, tailoring its product offerings to meet local needs, and investing in sales and marketing efforts.
  • Innovation in Clear Aligner Therapy: The clear aligner market is experiencing rapid growth, driven by increasing demand for discreet orthodontic solutions. DENTSPLY SIRONA's SureSmile clear aligner system provides a competitive offering in this market. Continued innovation and marketing efforts can drive further adoption and market share gains.
  • Development of Advanced Materials: The development and introduction of advanced dental materials, such as high-strength ceramics and biocompatible polymers, can drive growth by offering improved performance and aesthetics. DENTSPLY SIRONA can invest in research and development to create innovative materials that meet the evolving needs of dental professionals.
  • Strategic Acquisitions: Strategic acquisitions can provide DENTSPLY SIRONA with access to new technologies, products, and markets. By acquiring companies with complementary offerings, DENTSPLY SIRONA can expand its product portfolio, strengthen its market position, and accelerate its growth.

Chancen

  • Expansion in emerging markets with growing dental care demand.
  • Increasing adoption of digital dentistry and clear aligner therapy.
  • Strategic acquisitions to expand product portfolio and market reach.
  • Development of new and innovative dental materials and technologies.

Risiken

  • Intense competition from established players and emerging disruptors.
  • Regulatory changes and compliance requirements.
  • Product liability claims and recalls.
  • Economic downturns and reduced consumer spending on dental care.

Wettbewerbsvorteile

  • Established brand reputation and long history in the dental industry.
  • Extensive product portfolio covering a wide range of dental needs.
  • Global distribution network providing access to markets worldwide.
  • Strong relationships with dental professionals and institutions.
  • Significant investment in research and development, leading to innovative products.

Ueber XRAY

Founded in 1877 and headquartered in Charlotte, North Carolina, DENTSPLY SIRONA Inc. has evolved into one of the world's largest manufacturers of professional dental products and technologies. The company operates through two primary segments: Technologies & Equipment and Consumables. The Technologies & Equipment segment provides a wide array of dental equipment, including treatment centers, imaging equipment, and CAD/CAM technologies, enabling dental practitioners to perform various digital dental procedures. This segment also includes dentist-directed clear aligner solutions (SureSmile) and direct-to-consumer clear aligner solutions. The Consumables segment offers a comprehensive range of products, such as endodontic solutions, restorative materials, and small equipment products like intraoral curing light systems and dental diagnostic systems. DENTSPLY SIRONA's products are used by dentists, specialists, and dental laboratories worldwide, making it a key player in the global dental market. The company's extensive product portfolio and global distribution network provide a strong foundation for continued growth and innovation in the dental industry.

Was das Unternehmen tut

  • Manufactures and sells dental treatment centers.
  • Provides dental imaging equipment.
  • Offers motorized dental handpieces and other instruments.
  • Develops and markets dental CAD/CAM technologies.
  • Provides dentist-directed clear aligner solutions (SureSmile).
  • Offers endodontic products for root canal procedures.
  • Supplies restorative products like artificial teeth and dental ceramics.
  • Provides small equipment such as intraoral curing lights.

Geschaeftsmodell

  • Sells dental equipment and technology to dental professionals and institutions.
  • Generates revenue from the sale of consumable dental products.
  • Offers digital dentistry solutions, including CAD/CAM systems and clear aligners.
  • Provides after-sales service and support for its equipment.

Branchenkontext

DENTSPLY SIRONA operates in the global dental market, which is characterized by increasing demand for advanced dental technologies and cosmetic procedures. The market is driven by an aging population, rising disposable incomes, and growing awareness of oral health. The competitive landscape includes companies like AGIO, BEAM, BHC, CON, and HAE, each vying for market share with different product portfolios and geographic focuses. DENTSPLY SIRONA's broad product range and established distribution network position it well to capitalize on these trends, although it faces competition from both established players and emerging disruptors.

Wichtige Kunden

  • Dental practitioners and specialists.
  • Dental laboratories.
  • Hospitals and clinics.
  • Dental schools and universities.
KI-Zuversicht: 73% Aktualisiert: 8. Feb. 2026

Finanzdaten

Chart & Info

DENTSPLY SIRONA Inc. (XRAY) Aktienkurs: $11.54 (+0.59, +5.39%)

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer XRAY.

Kursziele

Konsens-Kursziel: $15.00

MoonshotScore

48/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von XRAY auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Haeufige Fragen zu XRAY

What are the key factors to evaluate for XRAY?

DENTSPLY SIRONA Inc. (XRAY) currently holds an AI score of 48/100, indicating low score. Analysts target $15.00 (+30% from $11.54). Key strength: Broad product portfolio covering various dental needs.. Primary risk to monitor: Ongoing: Intense competition from established players and emerging disruptors.. This is not financial advice.

How frequently does XRAY data refresh on this page?

XRAY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven XRAY's recent stock price performance?

Recent price movement in DENTSPLY SIRONA Inc. (XRAY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $15.00 implies 30% upside from here. Notable catalyst: Broad product portfolio covering various dental needs.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider XRAY overvalued or undervalued right now?

Determining whether DENTSPLY SIRONA Inc. (XRAY) is overvalued or undervalued requires examining multiple metrics. Analysts target $15.00 (+30% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying XRAY?

Before investing in DENTSPLY SIRONA Inc. (XRAY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding XRAY to a portfolio?

Potential reasons to consider DENTSPLY SIRONA Inc. (XRAY) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Broad product portfolio covering various dental needs.. Additionally: Global distribution network and established market presence.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of XRAY?

Yes, most major brokerages offer fractional shares of DENTSPLY SIRONA Inc. (XRAY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track XRAY's earnings and financial reports?

DENTSPLY SIRONA Inc. (XRAY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for XRAY earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available data and may be subject to change.
Datenquellen

Popular Stocks